• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

Access: Novartis Gives It Away

Article

Pharmaceutical Executive

Pharmaceutical ExecutivePharmaceutical Executive-07-01-2001
Volume 0
Issue 0

Basel, Switzerland -Novartis plans to provide its malaria drug, Coartem (artemether/lumefantrin), at cost to developing countries in partnership with the World Health Organization (WHO). The effort is only the latest in a series of moves intended to increase access to essential medicines after Big Pharma’s South Africa debacle.

Articles in this issue
Amgen's New Dream Team
Pharmacies: OTC Price Wars
One Disease at a Time
Overview of the Industry: A World of Opportunities
The Power Shift
Access: Novartis Gives It Away
A Giant Stumbles
CRO's Cross Over NOW
Overruled: No More Dual Pricing
Submerged
Generic Threat
Bottom Line Booster
Recent Videos
Related Content
Jeremy Truxal

Bringing Marketing to a New Audience: Q&A with Jeremy Truxal

Mike Hollan
September 20th 2024
Article

Truxal discusses Exact Science’s first Spanish language TV commercial and campaign for Cologuard.

Beyond the Birthrate: The Societal Costs of Maternal Mortality

Beyond the Birthrate: The Societal Costs of Maternal Mortality

Miranda Schmalfuhs
September 6th 2024
Podcast

Head of Medical Affairs and Outcomes Research at Organon, Charlotte Owens, MD, FACOG, discusses the most critical changes needed to close the gaps in R&D for maternal health solutions and how feasible they are to make.

Pharma Pulse 9/20/24: The Benefit to Adapting Operating Models, 50% of US Women Skip or Delay Medical Care & more

Pharma Pulse 9/20/24: The Benefit to Adapting Operating Models, 50% of US Women Skip or Delay Medical Care & more

Miranda Schmalfuhs
September 20th 2024
Article

The latest news for pharma industry insiders.

Empty Shelves, Urgent Solutions

Empty Shelves, Urgent Solutions

Miranda Schmalfuhs
August 5th 2024
Podcast

Michael Abrams, Managing Partner at Numerof & Associates discusses pharmacy deserts, alternative solutions to ensure continued access to medications for all Americans, potential long term consequences if these pharmacy closures continue, and more

Pharma Pulse 9/19/24: Coverage from DPHARM 2024, What’s Ahead for Food & more

Pharma Pulse 9/19/24: Coverage from DPHARM 2024, What’s Ahead for Food & more

Miranda Schmalfuhs
September 19th 2024
Article

The latest news for pharma industry insiders.

David Medina Tato

Four Key Strategies for Optimizing Your Medical Congress Strategy

David Medina Tato
September 19th 2024
Article

Conferences, congresses, and the digital discussions kicked off by those events create a halo effect that amplifies scientific information more so than other scientific activities.